DAVID R. HOFFMANN - Corporate Board Profile

DURECT CORP

Filing Date	Source Excerpt
2006-04-27	David R. Hoffmann has served as a director since December 2002. Mr. Hoffmann is retired from ALZA Corporation (now a Johnson & Johnson company) where he held the positions of Vice President and Treasurer from 1992 to until his retirement in October 2002.
2007-04-30	David R. Hoffmann has served as a director since December 2002. Mr. Hoffmann is retired from ALZA Corporation (now a Johnson & Johnson company) where he held the positions of Vice President and Treasurer from 1992 to until his retirement in October 2002.
2008-04-29	David R. Hoffmann has served as a director since December 2002. Mr. Hoffmann is retired from ALZA Corporation (now a Johnson & Johnson company) where he held the positions of Vice President and Treasurer from 1992 to until his retirement in October 2002.
2009-04-29	David R. Hoffmann has served as a director since December 2002. Mr. Hoffmann is retired from ALZA Corporation (now a Johnson & Johnson company) where he held the positions of Vice President and Treasurer from 1992 to until his retirement in October 2002.
2010-04-29	David R. Hoffmann has served as a director since December 2002. ... (1) Member of the Compensation Committee ... (2) Member of the Audit Committee ... Director Compensation for Fiscal 2009: David R. Hoffmann Fees Earned or Paid in Cash $72,500, Option Awards $32,324, Total $104,824.
2011-04-28	David R. Hoffmann has served as a director since December 2002 and as Lead Independent Director since December 2010. ... The Audit Committee was composed of the following directors: Simon X. Benito, David R. Hoffmann and Jon S. Saxe. Mr. Hoffmann has served as Chairman of the Audit Committee since September 2004. ... The Compensation Committee was composed of Michael D. Casey, David R. Hoffmann, Armand P. Neukermans and Jon S. Saxe. ... Director Compensation for Fiscal 2010: David R. Hoffmann $121,808.
2012-04-26	David R. Hoffmann has served as a director since December 2002 and as Lead Independent Director since December 2010. ... The Audit Committee was composed of the following directors: Simon X. Benito, David R. Hoffmann and Jon S. Saxe. Mr. Hoffmann has served as Chairman of the Audit Committee since September 2004. ... The Compensation Committee was composed of Michael D. Casey, David R. Hoffmann, Armand P. Neukermans and Jon S. Saxe. ... Director Compensation for Fiscal 2011: David R. Hoffmann total $126,563.
2013-04-29	David R. Hoffmann has served as a director since December 2002 and as Lead Independent Director since December 2010. ... Mr. Hoffmann is currently a member of the Board of Directors and chairman of the Audit Committee of Threshold Pharmaceuticals, a biotechnology company. Mr. Hoffmann’s financial and accounting expertise has caused the Board to designate him as the Audit Committee’s financial accounting expert.
2014-04-23	David R. Hoffmann has served as a director since December 2002 and as Lead Independent Director since December 2010. Mr. Hoffmann is retired from ALZA Corporation (now a Johnson & Johnson company) where he held the positions of Vice President and Treasurer from 1992 to until his retirement in October 2002, Vice President of Finance from 1982 to 1992, and Director of Accounting/Finance from 1976 to 1982. Mr. Hoffmann is currently Chief Executive Officer of Hoffmann Associates, a multi-group company specializing in cruise travel and financial and benefits consulting. Mr. Hoffmann holds a B.S. in Business Administration from the University of Colorado. Mr. Hoffmann is currently a member of the Board of Directors and chairman of the Audit Committee of Threshold Pharmaceuticals, a biotechnology company. Mr. Hoffmann’s financial and accounting expertise has caused the Board to designate him as the Audit Committee’s financial accounting expert. In addition, his pharmaceutical industry experience as relates to executive management, treasury, employee benefits and audit matters is an additional qualification he brings to the Board and his service as a Director of the Company.
2015-04-22	David R. Hoffmann has served as a director since December 2002 and as Lead Independent Director since December 2010. ... Mr. Hoffmann is currently a member of the Board of Directors and chairman of the Audit Committee of Threshold Pharmaceuticals, a biotechnology company. ... Mr. Hoffmann's financial and accounting expertise has caused the Board to designate him as the Audit Committee's financial accounting expert. ... In addition, his pharmaceutical industry experience as relates to executive management, treasury, employee benefits and audit matters is an additional qualification he brings to the Board and his service as a Director of the Company.
2016-04-28	David R. Hoffmann has served as a director since December 2002 and as Lead Independent Director since December 2010.
2017-04-27	David R. Hoffmann has served as a director since December 2002 and as Lead Independent Director since December 2010. ... The Audit Committee was composed of the following directors: Simon X. Benito, David R. Hoffmann and Jon S. Saxe. Mr. Hoffmann has served as Chairman of the Audit Committee since September 2004. ... The Compensation Committee was composed of Simon X. Benito, David R. Hoffmann, Armand P. Neukermans and Jon S. Saxe.
2018-04-27	David R. Hoffmann has served as a director since December 2002 and as Lead Independent Director since December 2010. ... Mr. Hoffmann is currently a member of the Board of Directors and chairman of the Audit Committee of Molecular Templates, an oncology company. ... Mr. Hoffmann’s financial and accounting expertise has caused the Board to designate him as the Audit Committee’s financial accounting expert.
2019-04-26	David R. Hoffmann (1)(2) 74 Chairman of the Board, Chairman of the Audit Committee (1) Member of the Compensation Committee (2) Member of the Audit Committee Director Compensation for Fiscal 2018 David R. Hoffmann Fees Earned or Paid in Cash ($) 55,633 Option Awards ($) 90,244 Total ($) 145,877
2020-04-27	David R. Hoffmann (1)(2) 75 Chairman of the Board, Chairman of the Audit Committee ... (1) Member of the Compensation Committee (2) Member of the Audit Committee ... Director Compensation for Fiscal 2019 David R. Hoffmann 108,000 Fees Earned or Paid in Cash ($) 25,604 Option Awards ($) — All Other Compensation ($) 133,604 Total ($)
2021-04-23	David R. Hoffmann has served as a director since December 2002 and was appointed Chairman of the Board effective January 1, 2019. ... Mr. Hoffmann is currently a member of the Board of Directors and chairman of the Audit Committee of Molecular Templates, an oncology company. ... Mr. Hoffmann’s financial and accounting expertise has caused the Board to designate him as the Audit Committee’s financial accounting expert.
2022-04-25	David R. Hoffmann has served on our Board of Directors since December 2002 and was appointed Chairman of the Board effective January 1, 2019. ... Mr. Hoffmann has served as Chairman of the Audit Committee since September 2004. ... At the end of the last fiscal year, the Compensation Committee was composed of Mohammad Azab, David R. Hoffmann and Gail J. Maderis. ... At the end of the last fiscal year, the Audit Committee was composed of the following directors: Simon X. Benito, Peter S. Garcia, David R. Hoffmann, Gail J. Maderis and Judy J. Robertson.
2022-10-07	Includes 363,000 shares held by David R. Hoffmann Trustee under the Trust of David R. Hoffmann and Judy A. Hoffmann U/A dated November 14, 1979 and 5,000 shares held in a Non-Exempt Marital Trust, David R. Hoffmann Trustee under the David R. Hoffmann and Judy A. Hoffmann Trust U/A dated November 14, 1979.
2023-04-27	David R. Hoffmann has served on our Board of Directors since December 2002 and was appointed Chair of the Board effective January 1, 2019 and served as Chair until March 2023. ... At the end of the last fiscal year, the Audit Committee was composed of the following directors: Peter S. Garcia, David R. Hoffmann, Gail J. Maderis and Judy J. Robertson. Mr. Hoffmann has served as Chair of the Audit Committee since September 2004. ... At the end of the last fiscal year, the Compensation Committee was composed of Mohammad Azab, Peter S. Garcia, David R. Hoffmann and Gail J. Maderis. ... Director Compensation for Fiscal 2022: David R. Hoffmann Fees Earned or Paid in Cash ($) 98,500, Option Awards ($) 23,150, Total ($) 121,650.